Ipca Laboratories, ING Vysya Bank, Rural Electrification Corporation and Jaiprakash Associates are among the other gainers.
Pharmaceutical company Ranbaxy Laboratories surged 8.75% to Rs 444.25. The stock topped the gainers in the BSE's 'A' group.
Pharmaceutical company Ipca Laboratories spurted 8.24% to Rs 699.90. The stock was second biggest gainer in 'A' group. The company announced during trading hours today, 4 September 2013, that the United States Food and Drug Administration (USFDA), following an inspection, has found acceptable the company's oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur, Madhya Pradesh. This will enable the company to commercialize oral solid dosage formulations in the US market from this formulations manufacturing facility.
It may be recalled that Ipca Laboratories had on 8 November 2012, said that during the course of the internal quality assurance review, the company had noticed a few non-conformances at its Indore manufacturing unit. The company had voluntarily referred these to the USFDA for an appropriate resolution, Ipca Laboratories said at that time.
ING Vysya Bank galloped 7.07% to Rs 439. The stock was third biggest gainer in 'A' group.
Power finance company Rural Electrification Corporation jumped 6.56% to Rs 175.50. The stock was fourth biggest gainer in 'A' group. The company announced after market hours on Tuesday, 3 September 2013, that its wholly-owned subsidiary, REC Transmission Projects Company (RECTPCL), transferred its wholly-owned subsidiary, Vizag Transmission (VTL), to Power Grid Corporation of India.
RECTPCL has received an acquisition price of Rs 15.41 crore from Power Grid Corporation of India towards acquisition of VTL along with its all assets and liabilities.
Infrastructure company Jaiprakash Associates climbed 6.28% to Rs 36.40 on media reports that the company's deal with UltraTech Cement is expected to be announced by tomorrow, 5 September 2013. The stock was fifth biggest gainer in 'A' group.
According to recent media reports, UltraTech Cement is close to buying Jaiprakash Associates' Gujarat cement plant for about Rs 3700 crore. Both the companies have been in discussions for the 4.8 million tonne per annum plant for more than a year, reports added. The likely deal will help Jaiprakash Associates to reduce debt and help UltraTech Cement to ramp up capacity. Shares of UltraTech Cement rose 2.51% to Rs 1,477.75.
Powered by Capital Market - Live News
